345 results on '"Willmann, M"'
Search Results
102. 18-F-Markierte Phenylpiperazine als neue Strukturmotive für spezifische Dopamin D4-Rezeptorliganden
- Author
-
Willmann, M, Ermert, J, and Neumaier, B
- Published
- 2019
- Full Text
- View/download PDF
103. Novel approaches to microfluidic components in high-end medical applications.
- Author
-
Goettsche, T., Kohnle, J., Willmann, M., Ernst, H., Messner, S., Steger, R., Storz, M., Lang, W., Zengerle, R., and Sandmaier, H.
- Published
- 2003
- Full Text
- View/download PDF
104. Microvalves for implantable microdosage systems.
- Author
-
Ernst, H., Willmann, M., Goettsche, T., Kohnle, J., Sandmaier, H., and Zengerle, R.
- Published
- 2002
- Full Text
- View/download PDF
105. Unravelling PTGS: SDE3 - an RNA helicase involved in RNA silencing in Arabidopsis
- Author
-
Willmann, M. R.
- Published
- 2001
- Full Text
- View/download PDF
106. Arabidopsis enters the post-sequencing era
- Author
-
Willmann, M. R.
- Published
- 2001
- Full Text
- View/download PDF
107. Studying the historic migrations of the Irish potato famine pathogen using ancient DNA
- Author
-
Willmann, M. R.
- Published
- 2001
- Full Text
- View/download PDF
108. Sterols as regulators of plant embryogenesis
- Author
-
Willmann, M. R.
- Published
- 2000
- Full Text
- View/download PDF
109. CLV1 and CLV3: negative regulators of SAM stem cell accumulation
- Author
-
Willmann, M. R.
- Published
- 2000
- Full Text
- View/download PDF
110. P-2-231 - Local neurosarcoidosis radiographically misdiagnosed as a meningioma
- Author
-
Willmann, M., Hussein, S., and Fedorowski, A.
- Published
- 1997
- Full Text
- View/download PDF
111. Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms
- Author
-
Mathias Müller, Erika Jensen-Jarolim, Emir Hadzijusufovic, Olivier Hermine, Gregor Eisenwort, Peter Valent, David M. Vail, Susanne Gamperl, Mauro Dacasto, Michel Arock, Barbara Peter, Karin Bauer, Laura Marconato, Michael Willmann, Willmann M., Hadzijusufovic E., Hermine O., Dacasto M., Marconato L., Bauer K., Peter B., Gamperl S., Eisenwort G., Jensen-Jarolim E., Muller M., Arock M., Vail D.M., and Valent P.
- Subjects
Oncology ,medicine.medical_specialty ,Poor prognosis ,CD30 ,040301 veterinary sciences ,tryptase ,KIT mutation ,Antineoplastic Agents ,Tryptase ,Review Article ,Antineoplastic Agent ,0403 veterinary science ,03 medical and health sciences ,Dogs ,0302 clinical medicine ,Species Specificity ,Skin tumours ,Internal medicine ,Dog ,medicine ,Animals ,Humans ,Dog Diseases ,CD25 ,Short survival ,General Veterinary ,biology ,Animal ,business.industry ,Treatment options ,Mastocytoma ,04 agricultural and veterinary sciences ,KIT mutations ,medicine.disease ,Mast cell ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,biology.protein ,Veterinary (all) ,Dog Disease ,canine mast cell neoplasm ,business ,Human - Abstract
In humans, advanced mast cell (MC) neoplasms are rare malignancies with a poor prognosis. Only a few preclinical models are available, and current treatment options are limited. In dogs, MC neoplasms are the most frequent malignant skin tumours. Unlike low-grade MC neoplasms, high-grade MC disorders usually have a poor prognosis with short survival. In both species, neoplastic MCs display activating KIT mutations, which are considered to contribute to disease evolution. Therefore, tyrosine kinase inhibitors against KIT have been developed. Unfortunately, clinical responses are unpredictable and often transient, which remains a clinical challenge in both species. Therefore, current efforts focus on the development of new improved treatment strategies. The field of comparative oncology may assist in these efforts and accelerate human and canine research regarding diagnosis, prognostication, and novel therapies. In this article, we review the current status of comparative oncology approaches and perspectives in the field of MC neoplasms.
- Published
- 2018
112. Research update for articles published in EJCI in 2009
- Author
-
Abed, Majed, Adlbrecht, Christopher, Amado Señarís, Jose Antonio, Amighi, Jasmin, Ankersmit, Hendrik J., de Berrazueta, Jose R., Bobbioni-Harsch, Elisabetta, Boyle, Kathryn, Buechler, Christa, Buemi, Michele, Cernaro, Valeria, Chang, Je-Ken, Chen, Chung-Hwan, Cheng, Wen-Ping, Cuocolo, Alberto, Dullaart, Robin P. F., Ghafourifar, Pedram, Guzik, Przemyslaw, Hoffmann, Michael M., Jurado, Jeroni, Kytö, Ville, Lang, Florian, Lichtenauer, Michael, Lin, Zu-Yau, Minami, Yoshitaka, Montero, David, Mookadam, Farouk, Nicolai, Emanuele, Pacher, Richard, Rahimian, Reza, Satoh, Mamoru, Saukko, Pekka, Selzer, Edgar, Shyu, Kou-Gi, Sztajzel, Juan, Vinet, Agnès, Walter, Martin A., Willmann, Michael, Winkler, Karl, Wykretowicz, Andrzej, Köker, Mustafa Y., Ybarra, Juan, Lifestyle Medicine (LM), Abed, M, Adlbrecht, C, Amado Señarís, Ja, Amighi, J, Ankersmit, Hi, de Berrazueta, Jr, Bobbioni Harsch, E, Boyle, K, Buechler, C, Buemi, M, Cernaro, V, Chang, J, Chen, C, Cheng, W, Cuocolo, Alberto, Dullaart, Rpf, Ghafourifar, P, Guzik, P, Hoffmann, Mm, Jurado, J, Kytö, V, Lang, F, Lichtenauer, M, Lin, Z, Minami, Y, Montero, D, Mookadam, F, Nicolai, E, Pacher, R, Rahimian, R, Satoh, M, Saukko, P, Selzer, E, Shyu, K, Sztajzel, J, Vinet, A, Walter, Ma, Willmann, M, Winkler, K, Wykretowicz, A, Köker, Mj, and Ybarra, J.
- Subjects
CHRONIC GRANULOMATOUS-DISEASE ,LONG-TERM OUTCOMES ,CARDIAC RESYNCHRONIZATION ,ENDOTHELIAL FUNCTION ,CORONARY-ARTERY-DISEASE ,TYPE-2 DIABETES-MELLITUS ,HEART-FAILURE ,TROPONIN AUTOANTIBODIES ,RADIOIODINE THERAPY ,INTIMA-MEDIA THICKNESS - Abstract
s
- Published
- 2011
113. Prognostic Value of Gut Microbiome for Conversion from Mild Cognitive Impairment to Alzheimer's Disease Dementia within 4 Years: Results from the AlzBiom Study.
- Author
-
Laske C, Müller S, Munk MHJ, Honold I, Willmann M, Peter S, and Schoppmeier U
- Subjects
- Humans, Longitudinal Studies, Prognosis, Disease Progression, Biomarkers, Alzheimer Disease genetics, Gastrointestinal Microbiome genetics, Cognitive Dysfunction etiology
- Abstract
Alterations in the gut microbiome are associated with the pathogenesis of Alzheimer's disease (AD) and can be used as a diagnostic measure. However, longitudinal data of the gut microbiome and knowledge about its prognostic significance for the development and progression of AD are limited. The aim of the present study was to develop a reliable predictive model based on gut microbiome data for AD development. In this longitudinal study, we investigated the intestinal microbiome in 49 mild cognitive impairment (MCI) patients over a mean (SD) follow-up of 3.7 (0.6) years, using shotgun metagenomics. At the end of the 4-year follow-up (4yFU), 27 MCI patients converted to AD dementia and 22 MCI patients remained stable. The best taxonomic model for the discrimination of AD dementia converters from stable MCI patients included 24 genera, yielding an area under the receiver operating characteristic curve (AUROC) of 0.87 at BL, 0.92 at 1yFU and 0.95 at 4yFU. The best models with functional data were obtained via analyzing 25 GO (Gene Ontology) features with an AUROC of 0.87 at BL, 0.85 at 1yFU and 0.81 at 4yFU and 33 KO [Kyoto Encyclopedia of Genes and Genomes (KEGG) ortholog] features with an AUROC of 0.79 at BL, 0.88 at 1yFU and 0.82 at 4yFU. Using ensemble learning for these three models, including a clinical model with the four parameters of age, gender, body mass index (BMI) and Apolipoprotein E (ApoE) genotype, yielded an AUROC of 0.96 at BL, 0.96 at 1yFU and 0.97 at 4yFU. In conclusion, we identified novel and timely stable gut microbiome algorithms that accurately predict progression to AD dementia in individuals with MCI over a 4yFU period.
- Published
- 2024
- Full Text
- View/download PDF
114. 7-[ 18 F]Fluoro-8-azaisatoic Anhydrides: Versatile Prosthetic Groups for the Preparation of PET Tracers.
- Author
-
Gröner B, Willmann M, Donnerstag L, Urusova EA, Neumaier F, Humpert S, Endepols H, Neumaier B, and Zlatopolskiy BD
- Subjects
- Animals, Rats, Amines, Anhydrides, Positron-Emission Tomography, Fluorine Radioisotopes chemistry, Alkynes, Radiopharmaceuticals
- Abstract
18 F-Fluorination of sensitive molecules is often challenging, but can be accomplished under suitably mild conditions using radiofluorinated prosthetic groups (PGs). Herein, 1-alkylamino-7-[18 F]fluoro-8-azaisatoic anhydrides ([18 F]AFAs) are introduced as versatile18 F-labeled building blocks that can be used as amine-reactive or "click chemistry" PGs. [18 F]AFAs were efficiently prepared within 15 min by "on cartridge" radiolabeling of readily accessible trimethylammonium precursors. Conjugation with a range of amines afforded the corresponding 2-alkylamino-6-[18 F]fluoronicotinamides in radiochemical conversions (RCCs) of 15-98%. In addition, radiolabeling of alkyne- or azide-functionalized precursors with azidopropyl- or propargyl-substituted [18 F]AFAs using Cu-catalyzed click cycloaddition afforded the corresponding conjugates in RCCs of 44-88%. The practical utility of the PGs was confirmed by the preparation of three18 F-labeled PSMA ligands in radiochemical yields of 28-42%. Biological evaluation in rats demonstrated excellent in vivo stability of all three conjugates. In addition, one conjugate ([18 F]JK-PSMA-15) showed favorable imaging properties for high-contrast visualization of small PSMA-positive lesions.- Published
- 2023
- Full Text
- View/download PDF
115. Preparation and PET/CT imaging of implant directed 68 Ga-labeled magnetic nanoporous silica nanoparticles.
- Author
-
Polyak A, Harting H, Angrisani N, Herrmann T, Ehlert N, Meißner J, Willmann M, Al-Bazaz S, Ross TL, Bankstahl JP, and Reifenrath J
- Subjects
- Animals, Mice, Clodronic Acid, Gallium Radioisotopes, Tissue Distribution, Titanium, Disease Models, Animal, Magnetic Phenomena, Positron Emission Tomography Computed Tomography, Nanopores
- Abstract
Background: Implant infections caused by biofilm forming bacteria are a major threat in orthopedic surgery. Delivering antibiotics directly to an implant affected by a bacterial biofilm via superparamagnetic nanoporous silica nanoparticles could present a promising approach. Nevertheless, short blood circulation half-life because of rapid interactions of nanoparticles with the host's immune system hinder them from being clinically used. The aim of this study was to determine the temporal in vivo resolution of magnetic nanoporous silica nanoparticle (MNPSNP) distribution and the effect of PEGylation and clodronate application using PET/CT imaging and gamma counting in an implant mouse model., Methods: PEGylated and non-PEGylated MNPSNPs were radiolabeled with gallium-68 (
68 Ga), implementing the chelator tris(hydroxypyridinone). 36 mice were included in the study, 24 mice received a magnetic implant subcutaneously on the left and a titanium implant on the right hind leg. MNPSNP pharmacokinetics and implant accumulation was analyzed in dependence on PEGylation and additional clodronate application. Subsequently gamma counting was performed for further final analysis., Results: The pharmacokinetics and biodistribution of all radiolabeled nanoparticles could clearly be visualized and followed by dynamic PET/CT imaging. Both variants of68 Ga-labeled MNPSNP accumulated mainly in liver and spleen. PEGylation of the nanoparticles already resulted in lower liver uptakes. Combination with macrophage depletion led to a highly significant effect whereas macrophage depletion alone could not reveal significant differences. Although MNPSNP accumulation around implants was low in comparison to the inner organs in PET/CT imaging, gamma counting displayed a significantly higher %I.D./g for the tissue surrounding the magnetic implants compared to the titanium control. Additional PEGylation and/or macrophage depletion revealed no significant differences regarding nanoparticle accumulation at the implantation site., Conclusion: Tracking of68 Ga-labeled nanoparticles in a mouse model in the first critical hours post-injection by PET/CT imaging provided a better understanding of MNPSNP distribution, elimination and accumulation. Although PEGylation increases circulation time, nanoparticle accumulation at the implantation site was still insufficient for infection treatment and additional efforts are needed to increase local accumulation., (© 2023. BioMed Central Ltd., part of Springer Nature.)- Published
- 2023
- Full Text
- View/download PDF
116. Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives.
- Author
-
Valent P, Sadovnik I, Peter B, Ivanov D, Schulenburg A, Hadzijusufovic E, Willmann M, Rülicke T, Herrmann H, Rabitsch W, Karlic H, Gleixner KV, Sperr WR, Hoermann G, Dahlhoff M, Pfeilstöcker M, Keil F, Lion T, and Grunt TW
- Subjects
- Humans, Neoplastic Stem Cells pathology, Forecasting, Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy, Hematologic Neoplasms pathology
- Abstract
Introduction: The Vienna Cancer Stem Cell Club (VCSCC) was launched by a group of scientists in Vienna in 2002., Areas Covered: Major aims of the VCSCC are to support research on cancer stem cells (CSC) in hematopoietic malignancies and to translate CSC-related markers and targets into clinical application. A primary focus of research in the VCSCC is the leukemic stem cell (LSC). Between 2013 and 2021, members of the VCSCC established a special research program on myeloproliferative neoplasms and since 2008, members of the VCSCC run the Ludwig Boltzmann Institute for Hematology and Oncology. In all these years, the VCSCC provided a robust intellectual platform for translational hematology and LSC research in Vienna. Furthermore, the VCSCC interacts with several national and international study groups and societies in the field. Representatives of the VCSCC also organized a number of international meetings and conferences on neoplastic stem cells, including LSC, in the past 15 years, and contributed to the definition and classification of CSC/LSC and related pre-malignant and malignant conditions., Expert Opinion: The VCSCC will continue to advance the field and to develop LSC-detecting and LSC-eradicating concepts through which diagnosis, prognostication, and therapy of blood cancer patients should improve.
- Published
- 2023
- Full Text
- View/download PDF
117. Increased Vaccination Diversity Leads to Higher and Less-Variable Neutralization of TBE Viruses of the European Subtype.
- Author
-
Bestehorn-Willmann M, Girl P, Greiner F, Mackenstedt U, Dobler G, and Lang D
- Abstract
Tick-borne encephalitis (TBE) is an infectious disease of the central nervous system. The causative agent is the tick-borne encephalitis virus (TBEV), which is most commonly transmitted by tick bites, but which may also be transmitted through the consumption of raw dairy products or, in rare instances, via infected transfusions, transplants, or the slaughter of infected animals. The only effective preventive option is active immunization. Currently, two vaccines are available in Europe-Encepur
® and FSME-IMMUN® . In Central, Eastern, and Northern Europe, isolated TBEV genotypes belong mainly to the European subtype (TBEV-EU). In this study, we investigated the ability of these two vaccines to induce neutralizing antibodies against a panel of diverse natural TBEV-EU isolates from TBE-endemic areas in southern Germany and in regions of neighboring countries. Sera of 33 donors vaccinated with either FSME-IMMUN® , Encepur® , or a mixture of both were tested against 16 TBEV-EU strains. Phylogenetic analysis of the TBEV-EU genomes revealed substantial genetic diversity and ancestry of the identified 13 genotypic clades. Although all sera were able to neutralize the TBEV-EU strains, there were significant differences among the various vaccination groups. The neutralization assays revealed that the vaccination using the two different vaccine brands significantly increased neutralization titers, decreased intra-serum variance, and reduced the inter-virus variation.- Published
- 2023
- Full Text
- View/download PDF
118. Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
- Author
-
Ivanov D, Milosevic Feenstra JD, Sadovnik I, Herrmann H, Peter B, Willmann M, Greiner G, Slavnitsch K, Hadzijusufovic E, Rülicke T, Dahlhoff M, Hoermann G, Machherndl-Spandl S, Eisenwort G, Fillitz M, Sliwa T, Krauth MT, Bettelheim P, Sperr WR, Koller E, Pfeilstöcker M, Gisslinger H, Keil F, Kralovics R, and Valent P
- Subjects
- Animals, Mice, Calreticulin genetics, Janus Kinase 2 genetics, Mutation, Neoplastic Stem Cells, Nuclear Proteins genetics, Phenotype, Transcription Factors genetics, Humans, Leukemia, Myeloid, Acute, Myeloproliferative Disorders genetics, Polycythemia Vera genetics
- Abstract
Myeloproliferative neoplasms (MPN) are characterized by uncontrolled expansion of myeloid cells, disease-related mutations in certain driver-genes including JAK2, CALR, and MPL, and a substantial risk to progress to secondary acute myeloid leukemia (sAML). Although behaving as stem cell neoplasms, little is known about disease-initiating stem cells in MPN. We established the phenotype of putative CD34
+ /CD38- stem cells and CD34+ /CD38+ progenitor cells in MPN. A total of 111 patients with MPN suffering from polycythemia vera, essential thrombocythemia, or primary myelofibrosis (PMF) were examined. In almost all patients tested, CD34+ /CD38- stem cells expressed CD33, CD44, CD47, CD52, CD97, CD99, CD105, CD117, CD123, CD133, CD184, CD243, and CD274 (PD-L1). In patients with PMF, MPN stem cells often expressed CD25 and sometimes also CD26 in an aberrant manner. MPN stem cells did not exhibit substantial amounts of CD90, CD273 (PD-L2), CD279 (PD-1), CD366 (TIM-3), CD371 (CLL-1), or IL-1RAP. The phenotype of CD34+ /CD38- stem cells did not change profoundly during progression to sAML. The disease-initiating capacity of putative MPN stem cells was confirmed in NSGS mice. Whereas CD34+ /CD38- MPN cells engrafted in NSGS mice, no substantial engraftment was produced by CD34+ /CD38+ or CD34- cells. The JAK2-targeting drug fedratinib and the BRD4 degrader dBET6 induced apoptosis and suppressed proliferation in MPN stem cells. Together, MPN stem cells display a unique phenotype, including cytokine receptors, immune checkpoint molecules, and other clinically relevant target antigens. Phenotypic characterization of neoplastic stem cells in MPN and sAML should facilitate their enrichment and the development of stem cell-eradicating (curative) therapies., (© 2023 The Authors. American Journal of Hematology published by Wiley Periodicals LLC.)- Published
- 2023
- Full Text
- View/download PDF
119. Engraftment in NSG SCF mice correlates with the WHO category and prognosis in systemic mastocytosis.
- Author
-
Willmann M, Peter B, Slavnitsch K, Berger D, Witzeneder N, Stefanzl G, Eisenwort G, Ivanov D, Sadovnik I, Hadzijusufovic E, Greiner G, Bernthaler T, Hoermann G, Dahlhoff M, Rülicke T, and Valent P
- Subjects
- Animals, Mice, Prognosis, World Health Organization, Mastocytosis, Systemic
- Published
- 2023
- Full Text
- View/download PDF
120. The Emergence and Dynamics of Tick-Borne Encephalitis Virus in a New Endemic Region in Southern Germany.
- Author
-
Lang D, Chitimia-Dobler L, Bestehorn-Willmann M, Lindau A, Drehmann M, Stroppel G, Hengge H, Mackenstedt U, Kaier K, Dobler G, and Borde J
- Abstract
Tick-borne encephalitis (TBE) is the most important viral tick-borne infection in Europe and Asia. It is emerging in new areas. The mechanisms of emergence are fairly unknown or speculative. In the Ravensburg district in southern Germany, TBE emerged, mainly over the last five years. Here, we analyzed the underlying epidemiology in humans. The resulting identified natural foci of the causal TBE virus (TBEV) were genetically characterized. We sampled 13 potential infection sites at these foci and detected TBEV in ticks ( Ixodes ricinus ) at eight sites. Phylogenetic analysis spurred the introduction of at least four distinct TBEV lineages of the European subtype into the Ravensburg district over the last few years. In two instances, a continuous spread of these virus strains over up to 10 km was observed.
- Published
- 2022
- Full Text
- View/download PDF
121. Increased regional ventilation as early imaging marker for future disease progression of interstitial lung disease: a feasibility study.
- Author
-
Scharm SC, Schaefer-Prokop C, Willmann M, Vogel-Claussen J, Knudsen L, Jonigk D, Fuge J, Welte T, Wacker F, Prasse A, and Shin HO
- Subjects
- Disease Progression, Feasibility Studies, Humans, Male, Retrospective Studies, Idiopathic Pulmonary Fibrosis diagnostic imaging, Lung diagnostic imaging
- Abstract
Objectives: Idiopathic pulmonary fibrosis (IPF) is a disease with a poor prognosis and a highly variable course. Pathologically increased ventilation-accessible by functional CT-is discussed as a potential predecessor of lung fibrosis. The purpose of this feasibility study was to investigate whether increased regional ventilation at baseline CT and morphological changes in the follow-up CT suggestive for fibrosis indeed occur in spatial correspondence., Methods: In this retrospective study, CT scans were performed at two time points between September 2016 and November 2020. Baseline ventilation was divided into four categories ranging from low, normal to moderately, and severely increased (C1-C4). Correlation between baseline ventilation and volume and density change at follow-up was investigated in corresponding voxels. The significance of the difference of density and volume change per ventilation category was assessed using paired t-tests with a significance level of p ≤ 0.05. The analysis was performed separately for normal (NAA) and high attenuation areas (HAA)., Results: The study group consisted of 41 patients (73 ± 10 years, 36 men). In both NAA and HAA, significant increases of density and loss of volume were seen in areas of severely increased ventilation (C4) at baseline compared to areas of normal ventilation (C2, p < 0.001). In HAA, morphological changes were more heterogeneous compared to NAA., Conclusion: Functional CT assessing the extent and distribution of lung parenchyma with pathologically increased ventilation may serve as an imaging marker to prospectively identify lung parenchyma at risk for developing fibrosis., Key Points: • Voxelwise correlation of serial CT scans suggests spatial correspondence between increased ventilation at baseline and structural changes at follow-up. • Regional assessment of pathologically increased ventilation at baseline has the potential to prospectively identify tissue at risk for developing fibrosis. • Presence and extent of pathologically increased ventilation may serve as an early imaging marker of disease activity., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
122. BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph + chronic myeloid leukemia.
- Author
-
Peter B, Eisenwort G, Sadovnik I, Bauer K, Willmann M, Rülicke T, Berger D, Stefanzl G, Greiner G, Hoermann G, Keller A, Wolf D, Čulen M, Winter GE, Hoffmann T, Schiefer AI, Sperr WR, Zuber J, Mayer J, and Valent P
- Subjects
- Animals, Blast Crisis drug therapy, Cell Cycle Proteins, Cell Line, Tumor, Drug Resistance, Neoplasm, Fusion Proteins, bcr-abl, Humans, Mice, Protein Kinase Inhibitors pharmacology, Protein Kinase Inhibitors therapeutic use, Proto-Oncogene Proteins c-myc, Stem Cells, Transcription Factors genetics, Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy, Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics, Leukemia, Myelogenous, Chronic, BCR-ABL Positive metabolism, Nuclear Proteins genetics
- Abstract
In most patients with chronic myeloid leukemia (CML) clonal cells can be kept under control by BCR::ABL1 tyrosine kinase inhibitors (TKI). However, overt resistance or intolerance against these TKI may occur. We identified the epigenetic reader BRD4 and its downstream-effector MYC as growth regulators and therapeutic targets in CML cells. BRD4 and MYC were found to be expressed in primary CML cells, CD34
+ /CD38- leukemic stem cells (LSC), and in the CML cell lines KU812, K562, KCL22, and KCL22T315I . The BRD4-targeting drug JQ1 was found to suppress proliferation in KU812 cells and primary leukemic cells in the majority of patients with chronic phase CML. In the blast phase of CML, JQ1 was less effective. However, the BRD4 degrader dBET6 was found to block proliferation and/or survival of primary CML cells in all patients tested, including blast phase CML and CML cells exhibiting the T315I variant of BCR::ABL1. Moreover, dBET6 was found to block MYC expression and to synergize with BCR::ABL1 TKI in inhibiting the proliferation in the JQ1-resistant cell line K562. Furthermore, BRD4 degradation was found to overcome osteoblast-induced TKI resistance of CML LSC in a co-culture system and to block interferon-gamma-induced upregulation of the checkpoint antigen PD-L1 in LSC. Finally, dBET6 was found to suppress the in vitro survival of CML LSC and their engraftment in NSG mice. Together, targeting of BRD4 and MYC through BET degradation sensitizes CML cells against BCR::ABL1 TKI and is a potent approach to overcome multiple forms of drug resistance in CML LSC., (© 2022 The Authors. American Journal of Hematology published by Wiley Periodicals LLC.)- Published
- 2022
- Full Text
- View/download PDF
123. CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251.
- Author
-
Hucke FIL, Bestehorn-Willmann M, Bassetto M, Brancale A, Zanetta P, and Bugert JJ
- Subjects
- Antiviral Agents pharmacology, Antiviral Agents therapeutic use, Brazil, Cell Line, Chlorocebus aethiops, Host Specificity, Humans, Virus Replication, Chikungunya Fever, Chikungunya virus genetics, Glioblastoma genetics
- Abstract
Chikungunya virus (CHIKV), a (re)emerging arbovirus, is the causative agent of chikungunya fever. To date, no approved vaccine or specific antiviral therapy are available. CHIKV has repeatedly been responsible for serious economic and public health impacts in countries where CHIKV epidemics occurred. Antiviral tests in vitro are generally performed in Vero-B4 cells, a well characterised cell line derived from the kidney of an African green monkey. In this work we characterised a CHIKV patient isolate from Brazil (CHIKV
Brazil ) with regard to cell affinity, infectivity, propagation and cell damage and compared it with a high-passage lab strain (CHIKVRoss ). Infecting various cell lines (Vero-B4, A549, Huh-7, DBTRG, U251, and U138) with both virus strains, we found distinct differences between the two viruses. CHIKVBrazil does not cause cytopathic effects (CPE) in the human hepatocarcinoma cell line Huh-7. Neither CHIKVBrazil nor CHIKVRoss caused CPE on A549 human lung epithelial cells. The human astrocyte derived glioblastoma cell lines U138 and U251 were found to be effective models for lytic infection with both virus strains and we discuss their predictive potential for neurogenic CHIKV disease. We also detected significant differences in antiviral efficacies regarding the two CHIKV strains. Generally, the antivirals ribavirin, hydroxychloroquine (HCQ) and T-1105 seem to work better against CHIKVBrazil in glioblastoma cells than in Vero-B4. Finally, full genome analyses of the CHIKV isolates were done in order to determine their lineage and possibly explain differences in tissue range and antiviral compound efficacies., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2022
- Full Text
- View/download PDF
124. Signature of Alzheimer's Disease in Intestinal Microbiome: Results From the AlzBiom Study.
- Author
-
Laske C, Müller S, Preische O, Ruschil V, Munk MHJ, Honold I, Peter S, Schoppmeier U, and Willmann M
- Abstract
Background: Changes in intestinal microbiome composition have been described in animal models of Alzheimer's disease (AD) and AD patients. Here we investigated how well taxonomic and functional intestinal microbiome data and their combination with clinical data can be used to discriminate between amyloid-positive AD patients and cognitively healthy elderly controls., Methods: In the present study we investigated intestinal microbiome in 75 amyloid-positive AD patients and 100 cognitively healthy controls participating in the AlzBiom study. We randomly split the data into a training and a validation set. Intestinal microbiome was measured using shotgun metagenomics. Receiver operating characteristic (ROC) curve analysis was performed to examine the discriminatory ability of intestinal microbiome among diagnostic groups., Results: The best model for discrimination of amyloid-positive AD patients from healthy controls with taxonomic data was obtained analyzing 18 genera features, and yielded an area under the receiver operating characteristic curve (AUROC) of 0.76 in the training set and 0.61 in the validation set. The best models with functional data were obtained analyzing 17 GO (Gene Ontology) features with an AUROC of 0.81 in the training set and 0.75 in the validation set and 26 KO [Kyoto Encyclopedia of Genes and Genomes (KEGG) ortholog] features with an AUROC of 0.83 and 0.77, respectively. Using ensemble learning for these three models including a clinical model with the 4 parameters age, gender, BMI and ApoE yielded an AUROC of 0.92 in the training set and 0.80 in the validation set., Discussion: In conclusion, we identified a specific Alzheimer signature in intestinal microbiome that can be used to discriminate amyloid-positive AD patients from healthy controls. The diagnostic accuracy increases from taxonomic to functional data and is even better when combining taxonomic, functional and clinical models. Intestinal microbiome represents an innovative diagnostic supplement and a promising area for developing novel interventions against AD., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Laske, Müller, Preische, Ruschil, Munk, Honold, Peter, Schoppmeier and Willmann.)
- Published
- 2022
- Full Text
- View/download PDF
125. New and Confirmed Foci of Tick-Borne Encephalitis Virus (TBEV) in Northern Germany Determined by TBEV Detection in Ticks.
- Author
-
Topp AK, Springer A, Dobler G, Bestehorn-Willmann M, Monazahian M, and Strube C
- Abstract
Tick-borne encephalitis (TBE) is a tick-transmitted, virus-induced neurological disease with potentially fatal outcomes in humans and animals. Virus transmission takes places in so-called tick-borne encephalitis virus (TBEV) microfoci, which constitute small areas of sustained virus circulation. In southern Germany, TBEV has been endemic for decades; however, a northward expansion of risk areas, based on disease incidence in the human population, has been observed in recent years. The present study investigated TBEV occurrence in questing ticks at eight locations in the federal state of Lower Saxony, northwestern Germany, chosen due to reported associations with human TBE cases (N = 4) or previous virus detection (N = 4). A total of 20,056 ticks were collected in 2020 and 2021 and tested for TBEV RNA in pools of ten nymphs or five adults by quantitative reverse transcription-PCR (RT-qPCR). Positive results were confirmed by RT amplification of the viral E gene. In total, 18 pools from five different sampling locations were positive for TBEV RNA. One previously unknown transmission focus was detected, while ongoing virus circulation was confirmed at the four further locations. Phylogenetic analysis showed that two different virus strains with different origins circulate in the locations identified as natural foci.
- Published
- 2022
- Full Text
- View/download PDF
126. Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.
- Author
-
Eisenwort G, Sadovnik I, Keller A, Ivanov D, Peter B, Berger D, Stefanzl G, Bauer K, Slavnitsch K, Greiner G, Gleixner KV, Sperr WR, Willmann M, Sill H, Bettelheim P, Geissler K, Deininger M, Rülicke T, and Valent P
- Subjects
- Aged, Aged, 80 and over, Animals, Antigens, CD34 metabolism, Apoptosis, Case-Control Studies, Cell Proliferation, Female, Humans, Leukemia, Myeloid, Acute etiology, Leukemia, Myeloid, Acute metabolism, Male, Mice, Mice, Inbred NOD, Mice, SCID, Middle Aged, Neoplastic Stem Cells drug effects, Neoplastic Stem Cells immunology, Neoplastic Stem Cells metabolism, Prognosis, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, Antigens, CD34 immunology, Leukemia, Myeloid, Acute pathology, Leukemia, Myelomonocytic, Chronic complications, Neoplastic Stem Cells pathology, Phenotype
- Abstract
Chronic myelomonocytic leukemia (CMML) is a stem cell-derived neoplasm characterized by dysplasia, uncontrolled expansion of monocytes, and substantial risk to transform to secondary acute myeloid leukemia (sAML). So far, little is known about CMML-initiating cells. We found that leukemic stem cells (LSC) in CMML reside in a CD34
+ /CD38- fraction of the malignant clone. Whereas CD34+ /CD38- cells engrafted NSGS mice with overt CMML, no CMML was produced by CD34+ /CD38+ progenitors or the bulk of CD34- monocytes. CMML LSC invariably expressed CD33, CD117, CD123 and CD133. In a subset of patients, CMML LSC also displayed CD52, IL-1RAP and/or CLL-1. CMML LSC did not express CD25 or CD26. However, in sAML following CMML, the LSC also expressed CD25 and high levels of CD114, CD123 and IL-1RAP. No correlations between LSC phenotypes, CMML-variant, mutation-profiles, or clinical course were identified. Pre-incubation of CMML LSC with gemtuzumab-ozogamicin or venetoclax resulted in decreased growth and impaired engraftment in NSGS mice. Together, CMML LSC are CD34+ /CD38- cells that express a distinct profile of surface markers and target-antigens. During progression to sAML, LSC acquire or upregulate certain cytokine receptors, including CD25, CD114 and CD123. Characterization of CMML LSC should facilitate their enrichment and the development of LSC-eradicating therapies., (© 2021. The Author(s), under exclusive licence to Springer Nature Limited.)- Published
- 2021
- Full Text
- View/download PDF
127. Long-term presence of tick-borne encephalitis virus in experimentally infected bank voles (Myodes glareolus).
- Author
-
Michelitsch A, Fast C, Sick F, Tews BA, Stiasny K, Bestehorn-Willmann M, Dobler G, Beer M, and Wernike K
- Subjects
- Animals, Encephalitis, Tick-Borne virology, Female, Germany, Male, Arvicolinae, Encephalitis Viruses, Tick-Borne physiology, Encephalitis, Tick-Borne veterinary
- Abstract
Tick-borne encephalitis virus (TBEV) is a vector-borne pathogen that can cause serious neurological symptoms in humans. Across large parts of Eurasia TBEV is found in three traditional subtypes: the European, the Siberian and the Far-eastern subtype. Small mammalian animals play an important role in the transmission cycle as they enable the spread of TBEV among the vector tick population. To assess the impact of TBEV infection on its natural hosts, outbred bank voles (Myodes glareolus) were inoculated with one out of four European TBEV strains. Three of these TBEV strains were recently isolated in Germany. The forth one was the TBEV reference strain Neudörfl. Sampling points at 7, 14, 28, and 56 days post inoculation allowed the characterization of the course of infection. At each time point, six animals per strain were euthanized and eleven organ samples (brain, spine, lung, heart, small and large intestine, liver, spleen, kidney, bladder, sexual organ) as well as whole blood and serum samples were collected. The majority of bank voles (92/96) remained clinically unaffected after the inoculation with TBEV, but still developed a systemic infection during the first week, which transitioned to a viraemia and an infestation of the brain in some animals for the remainder of the first month. Viral RNA was found in whole blood samples of several animals (50/96), but only in a small fraction of the corresponding serum samples (4/50). From the whole blood, virus was successfully reisolated in cell culture until 14 days after inoculation. Less than five percent of all inoculated bank voles (4/96) displayed signs of distress in combination with a rapid weight loss and had to be euthanized prematurely. Overall, the recently isolated TBEV strains showed marked differences, such as a more frequent development of long-term viraemia and a higher detection rate of viral RNA in various organs, in comparison to the reference strain Neudörfl. Overall, our data suggest that the bank vole is a potential amplifying host in the TBEV transmission cycle and appears to be highly adapted to circulating TBEV strains., (Copyright © 2021 Elsevier GmbH. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
128. Needs for an Integration of Specific Data Sources and Items - First Insights of a National Survey Within the German Center for Infection Research.
- Author
-
Jakob CEM, Stecher M, Fuhrmann S, Wingen-Heimann S, Heinen S, Anton G, Behnke M, Behrends U, Boeker M, Castell S, Demski H, Diefenbach M, Falgenhauer JC, Fritzenwanker M, Gastmeier P, Gerhard M, Glöckner S, Golubovic M, Gunsenheimer Bartmeyer B, Ingenerf J, Kaiser R, Körner ML, Loag W, Mchardy A, Molitor E, Nübel U, Pritsch M, Ramharter M, Rieg SR, Rupp J, Schindler D, Schwudke D, Spinner C, Stottmeier B, Vehreschild M, Willmann M, and Vehreschild JJ
- Subjects
- Germany epidemiology, Humans, Information Storage and Retrieval, Surveys and Questionnaires, Communicable Diseases, Hospitals
- Abstract
State-subsidized programs develop medical data integration centers in Germany. To get infection disease (ID) researchers involved in the process of data sharing, common interests and minimum data requirements were prioritized. In 06/2019 we have initiated the German Infectious Disease Data Exchange (iDEx) project. We have developed and performed an online survey to determine prioritization of requests for data integration and exchange in ID research. The survey was designed with three sub-surveys, including a ranking of 15 data categories and 184 specific data items and a query of available 51 data collecting systems. A total of 84 researchers from 17 fields of ID research participated in the survey (predominant research fields: gastrointestinal infections n=11, healthcare-associated and antibiotic-resistant infections n=10, hepatitis n=10). 48% (40/84) of participants had experience as medical doctor. The three top ranked data categories were microbiology and parasitology, experimental data, and medication (53%, 52%, and 47% of maximal points, respectively). The most relevant data items for these categories were bloodstream infections, availability of biomaterial, and medication (88%, 87%, and 94% of maximal points, respectively). The ranking of requests of data integration and exchange is diverse and depends on the chosen measure. However, there is need to promote discipline-related digitalization and data exchange.
- Published
- 2021
- Full Text
- View/download PDF
129. Tick-Borne Encephalitis Vaccination Protects from Alimentary TBE Infection: Results from an Alimentary Outbreak.
- Author
-
Chitimia-Dobler L, Lindau A, Oehme R, Bestehorn-Willmann M, Antwerpen M, Drehmann M, Hierl T, Mackenstedt U, and Dobler G
- Abstract
In May 2017, a hospitalized index case of tick-borne encephalitis (TBE) was confirmed by Serology. The case was linked to alimentary infection by raw milk from a goat farm in the region of Tübingen, Baden-Württemberg, Germany, where no previous TBE cases in the area had been reported before. The TBE focus was confirmed by isolation of the TBE virus from ticks and Serological confirmation of past infection in one of the five flock goats. Additional investigations by the local public health office identified 27 consumers of goat milk at the putative period of exposure. For 20/27 exposed persons, anamnestic information was gained by the local public health office. Twelve/fourteen exposed and non-vaccinated people developed clinical illness and were confirmed as TBE cases by Serology. Five/six vaccinated and exposed people did not develop the disease. The one exposed and vaccinated person had their last TBE vaccination booster more than 15 years ago, and therefore a booster was more than 10 years overdue. None of the regularly vaccinated and exposed persons developed clinical overt TBE infection. We report the first known TBE outbreak, during which, protection by TBE vaccination against alimentary TBE infection was demonstrated.
- Published
- 2021
- Full Text
- View/download PDF
130. Comparison of whole genomes of tick-borne encephalitis virus from mountainous alpine regions and regions with a lower altitude.
- Author
-
Lemhöfer G, Chitimia-Dobler L, Dobler G, and Bestehorn-Willmann M
- Subjects
- Altitude, Encephalitis Viruses, Tick-Borne isolation & purification, Phylogeny, Tundra, Encephalitis Viruses, Tick-Borne genetics, Genome, Viral
- Abstract
Tick-borne encephalitis (TBE) has been a notifiable disease in Germany since 2001. Its causative agent, the TBE virus (TBEV), is the most important arbovirus in Europe and Northern Asia. The illness, caused by the European Subtype usually displays flu-like symptoms, but can result in sequelae and, in 2 % of all cases, in death. Over the last few decades, the virus has spread into new habitats, such as higher altitudes in the Alpine region. For this study, it was hypothesized that the environmental challenges that the virus might be exposed to at such altitudes could lead to the selection of viral strains with a higher resilience to such environmental factors. To determine whether strains identified at higher altitudes possessed different genetic traits compared to viruses from lower altitudes, an analysis of viral genomes from higher Alpine altitudes (> 500 m above sea level) (n = 5) and lower altitudes (< 500 m above sea level) (n = 4) was performed. No common phylogenetic ancestry or shared amino acid substitutions could be identified that differentiated the alpine from the lowland viral strains. These findings support the idea of many individual introductions of TBEV into the alpine region and the establishment of foci due to non-viral specific factors such as favorable conditions for vector species and host animals due to climate change.
- Published
- 2021
- Full Text
- View/download PDF
131. Radiosynthesis and Biological Evaluation of [ 18 F]R91150, a Selective 5-HT 2A Receptor Antagonist for PET-Imaging.
- Author
-
Willmann M, Hegger J, Neumaier B, and Ermert J
- Abstract
Serotonergic 5-HT
2A receptors in cortical and forebrain regions are an important substrate for the neuromodulatory actions of serotonin in the brain. They have been implicated in the etiology of many neuropsychiatric disorders and serve as a target for antipsychotic, antidepressant, and anxiolytic drugs. Positron emission tomography imaging using suitable radioligands can be applied for in vivo quantification of receptor densities and receptor occupancy for therapy evaluation. Recently, the radiosynthesis of the selective 5-HT2A R antagonist [18 F]R91150 was reported. However, the six-step radiosynthesis is cumbersome and time-consuming with low radiochemical yields (RCYs) of <5%. In this work, [18 F]R91150 was prepared using late-stage Cu-mediated radiofluorination to simplify its synthesis. The detailed protocol enabled us to obtain RCYs of 14 ± 1%, and the total synthesis time was reduced to 60 min. In addition, autoradiographic studies with [18 F]R91150 in rat brain slices revealed the typical uptake pattern of 5-HT2A receptor ligands., Competing Interests: The authors declare no competing financial interest., (© 2021 The Authors. Published by American Chemical Society.)- Published
- 2021
- Full Text
- View/download PDF
132. Prophylactic strategies to control chikungunya virus infection.
- Author
-
Hucke FIL, Bestehorn-Willmann M, and Bugert JJ
- Subjects
- Animals, Chikungunya Fever diagnosis, Chikungunya Fever epidemiology, Chikungunya virus physiology, Drug Development, Humans, Viral Vaccines, Antiviral Agents therapeutic use, Chikungunya Fever prevention & control, Pre-Exposure Prophylaxis
- Abstract
Chikungunya virus (CHIKV) is a (re)emerging arbovirus and the causative agent of chikungunya fever. In recent years, CHIKV was responsible for a series of outbreaks, some of which had serious economic and public health impacts in the affected regions. So far, no CHIKV-specific antiviral therapy or vaccine has been approved. This review gives a brief summary on CHIKV epidemiology, spread, infection and diagnosis. It furthermore deals with the strategies against emerging diseases, drug development and the possibilities of testing antivirals against CHIKV in vitro and in vivo. With our review, we hope to provide the latest information on CHIKV, disease manifestation, as well as on the current state of CHIKV vaccine development and post-exposure therapy.
- Published
- 2021
- Full Text
- View/download PDF
133. Transcriptomic Basis of Serum Resistance and Virulence Related Traits in XDR P. aeruginosa Evolved Under Antibiotic Pressure in a Morbidostat Device.
- Author
-
Javed M, Jentzsch B, Heinrich M, Ueltzhoeffer V, Peter S, Schoppmeier U, Angelov A, Schwarz S, and Willmann M
- Abstract
Colistin is a last resort antibiotic against the critical status pathogen Pseudomonas aeruginosa . Virulence and related traits such as biofilm formation and serum resistance after exposure to sub-inhibitory levels of colistin have been underexplored. We cultivated P. aeruginosa in a semi-automated morbidostat device with colistin, metronidazole and a combination of the two antibiotics for 21 days, and completed RNA-Seq to uncover the transcriptional changes over time. Strains became resistant to colistin within this time period. Colistin-resistant strains show significantly increased biofilm formation: the cell density in biofilm increases under exposure to colistin, while the addition of metronidazole can remove this effect. After 7 days of colistin exposure, strains develop an ability to grow in serum, suggesting that colistin drives bacterial modifications conferring a protective effect from serum complement factors. Of note, strains exposed to colistin showed a decrease in virulence, when measured using the Galleria mellonella infection model. These phenotypic changes were characterized by a series of differential gene expression changes, particularly those related to LPS modifications, spermidine synthesis ( via speH and speE ) and the major stress response regulator rpoS . Our results suggest a clinically important bacterial evolution under sub-lethal antibiotic concentration leading to potential for significant changes in the clinical course of infection., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Javed, Jentzsch, Heinrich, Ueltzhoeffer, Peter, Schoppmeier, Angelov, Schwarz and Willmann.)
- Published
- 2021
- Full Text
- View/download PDF
134. The Stable Matching Problem in TBEV Enzootic Circulation: How Important Is the Perfect Tick-Virus Match?
- Author
-
Liebig K, Boelke M, Grund D, Schicht S, Bestehorn-Willmann M, Chitimia-Dobler L, Dobler G, Jung K, and Becker SC
- Abstract
Tick-borne encephalitis virus (TBEV), like other arthropod-transmitted viruses, depends on specific vectors to complete its enzootic cycle. It has been long known that Ixodes ricinus ticks constitute the main vector for TBEV in Europe. In contrast to the wide distribution of the TBEV vector, the occurrence of TBEV transmission is focal and often restricted to a small parcel of land, whereas surrounding areas with seemingly similar habitat parameters are free of TBEV. Thus, the question arises which factors shape this focal distribution of TBEV in the natural habitat. To shed light on factors driving TBEV-focus formation, we used tick populations from two TBEV-foci in Lower Saxony and two TBEV-foci from Bavaria with their respective virus isolates as a showcase to analyze the impact of specific virus isolate-tick population relationships. Using artificial blood feeding and field-collected nymphal ticks as experimental means, our investigation showed that the probability of getting infected with the synonymous TBEV isolate as compared to the nonsynonymous TBEV isolate was elevated but significantly higher only in one of the four TBEV foci. More obviously, median viral RNA copy numbers were significantly higher in the synonymous virus-tick population pairings. These findings may present a hint for a coevolutionary adaptation of virus and tick populations.
- Published
- 2021
- Full Text
- View/download PDF
135. In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells.
- Author
-
Gamperl S, Stefanzl G, Willmann M, Valent P, and Hadzijusufovic E
- Subjects
- Animals, Dogs, Mast Cells drug effects, Mast Cells immunology, Cell Proliferation drug effects, Histamine Antagonists pharmacology, Histamine Release drug effects, Mast Cells physiology
- Abstract
Canine mastocytomas (MCTs) are characterized by rapid proliferation of neoplastic mast cells (MCs) and clinical signs caused by MC-derived mediators. In dogs suffering from MCT, histamine receptor 1 (HR1) antagonists are frequently used to control mediator-related clinical symptoms. Previous studies have shown that the HR1 antagonists loratadine and terfenadine exert some growth-inhibitory effects on neoplastic MCs. We examined whether other HR1 antagonists used in clinical practice (desloratadine, rupatadine, cyproheptadine, dimetindene, diphenhydramine) affect proliferation and survival of neoplastic MCs. Furthermore, we analysed whether these HR1 antagonists counteract IgE-dependent histamine release from a MC line harbouring a functional IgE-receptor. HR1 antagonists were applied on two canine MC lines, C2 and NI-1, and on primary MCs obtained from three MCT samples. The HR1 antagonists desloratadine, rupatadine and cyproheptadine were found to be more potent in decreasing proliferation of C2 and NI-1 cells when compared with dimetindene and diphenhydramine. Similar effects were seen in primary neoplastic MCs, except for diphenhydramine, which exerted more potent growth-inhibitory effects than the other HR1 antagonists. Drug-induced growth-inhibition in C2 and NI-1 cells was accompanied by apoptosis. Loratadine, desloratadine and rupatadine also suppressed IgE-dependent histamine release in NI-1 cells. However, drug concentrations required to elicit substantial effects on growth or histamine release were relatively high (>10 µM). Therefore, it remains unknown whether these drugs or similar, more potent, HR1-targeting drugs can suppress growth or activation of canine neoplastic MCs in vivo., (© 2020 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
136. Radiosynthesis and evaluation of 18 F-labeled dopamine D 4 -receptor ligands.
- Author
-
Willmann M, Ermert J, Prante O, Hübner H, Gmeiner P, and Neumaier B
- Subjects
- Ligands, Animals, Rats, Chemistry Techniques, Synthetic, Isotope Labeling, Male, Brain diagnostic imaging, Brain metabolism, Tissue Distribution, Humans, Fluorine Radioisotopes chemistry, Receptors, Dopamine D4 metabolism, Radiochemistry, Positron-Emission Tomography methods
- Abstract
Introduction: The dopamine D
4 receptor (D4 R) has attracted considerable attention as potential target for the treatment of a broad range of central nervous system disorders. Although many efforts have been made to improve the performance of putative radioligand candidates, there is still a lack of D4 R selective tracers suitable for in vivo PET imaging. Thus, the objective of this work was to develop a D4 -selective PET ligand for clinical applications., Methods: Four compounds based on previous and new lead structures were prepared and characterized with regard to their D4 R subtype selectivity and predicted lipophilicity. From these, 3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine I and (S)-4-(3-fluoro-4-methoxybenzyl)-2-(phenoxymethyl)morpholine II were selected for labeling with fluorine-18 and subsequent evaluation by in vitro autoradiography to assess their suitability as D4 radioligand candidates for in vivo imaging., Results: The radiosynthesis of [18 F]I and [18 F]II was successfully achieved by copper-mediated radiofluorination with radiochemical yields of 7% and 66%, respectively. The radioligand [18 F]II showed specific binding in areas where D4 expression is expected, whereas [18 F]I did not show any uptake in distinct brain regions and exhibited an unacceptable degree of non-specific binding., Conclusions: The compounds studied exhibited high D4 R subtype selectivity and logP values compatible with high brain uptake, but only ligand [18 F]II showed low non-specific binding and is therefore a good candidate for further evaluation., Advances in Knowledge: The discovery of new lead structures for high-affinity D4 ligands opens up new possibilities for the development of suitable PET-radioligands., Implications for Patient: PET-imaging of dopamine D4 -receptors could facilitate understanding, diagnosis and treatment of neuropsychiatric and neurodegenerative diseases., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
137. Whole genome sequencing and phylogenetic classification of Tunisian SARS-CoV-2 strains from patients of the Military Hospital in Tunis.
- Author
-
Handrick S, Bestehorn-Willmann M, Eckstein S, Walter MC, Antwerpen MH, Naija H, Stoecker K, Wölfel R, and Ben Moussa M
- Subjects
- Adult, Asymptomatic Diseases, COVID-19 diagnosis, COVID-19 transmission, COVID-19 virology, Europe epidemiology, Female, Hospitals, Military, Humans, Male, Middle Aged, Military Personnel, Morocco epidemiology, Pedigree, RNA, Viral genetics, SARS-CoV-2 classification, SARS-CoV-2 isolation & purification, Travel-Related Illness, Tunisia epidemiology, Viral Load, Whole Genome Sequencing, COVID-19 epidemiology, Genome, Viral, Pandemics, Phylogeny, SARS-CoV-2 genetics
- Abstract
In the present work, two complete genome sequences of SARS-CoV-2 were obtained from nasal swab samples of Tunisian SARS-CoV-2 PCR-positive patients using nanopore sequencing. The virus genomes of two of the patients examined, a Tunisian soldier returning from a mission in Morocco and a member of another Tunisian family, showed significant differences in analyses of the total genome and single nucleotide polymorphisms (SNPs). Phylogenetic relationships with known SARS-CoV-2 genomes in the African region, some European and Middle Eastern countries and initial epidemiological conclusions indicate that the introduction of SARS-CoV-2 into Tunisia from two independent sources was travel-related.
- Published
- 2020
- Full Text
- View/download PDF
138. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
- Author
-
Herrmann H, Sadovnik I, Eisenwort G, Rülicke T, Blatt K, Herndlhofer S, Willmann M, Stefanzl G, Baumgartner S, Greiner G, Schulenburg A, Mueller N, Rabitsch W, Bilban M, Hoermann G, Streubel B, Vallera DA, Sperr WR, and Valent P
- Subjects
- ADP-ribosyl Cyclase 1 genetics, Animals, Antigens, CD34, Humans, Mice, Mice, Inbred NOD, Neoplastic Stem Cells, Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics, Leukemia, Myeloid, Acute genetics
- Abstract
In an attempt to identify novel markers and immunological targets in leukemic stem cells (LSCs) in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML), we screened bone marrow (BM) samples from patients with AML (n = 274) or CML (n = 97) and controls (n = 288) for expression of cell membrane antigens on CD34+/CD38- and CD34+/CD38+ cells by multicolor flow cytometry. In addition, we established messenger RNA expression profiles in purified sorted CD34+/CD38- and CD34+/CD38+ cells using gene array and quantitative polymerase chain reaction. Aberrantly expressed markers were identified in all cohorts. In CML, CD34+/CD38- LSCs exhibited an almost invariable aberration profile, defined as CD25+/CD26+/CD56+/CD93+/IL-1RAP+. By contrast, in patients with AML, CD34+/CD38- cells variably expressed "aberrant" membrane antigens, including CD25 (48%), CD96 (40%), CD371 (CLL-1; 68%), and IL-1RAP (65%). With the exception of a subgroup of FLT3 internal tandem duplication-mutated patients, AML LSCs did not exhibit CD26. All other surface markers and target antigens detected on AML and/or CML LSCs, including CD33, CD44, CD47, CD52, CD105, CD114, CD117, CD133, CD135, CD184, and roundabout-4, were also found on normal BM stem cells. However, several of these surface targets, including CD25, CD33, and CD123, were expressed at higher levels on CD34+/CD38- LSCs compared with normal BM stem cells. Moreover, antibody-mediated immunological targeting through CD33 or CD52 resulted in LSC depletion in vitro and a substantially reduced LSC engraftment in NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice. Together, we have established surface marker and target expression profiles of AML LSCs and CML LSCs, which should facilitate LSC enrichment, diagnostic LSC phenotyping, and development of LSC-eradicating immunotherapies., (© 2020 by The American Society of Hematology.)
- Published
- 2020
- Full Text
- View/download PDF
139. Tracking of Antibiotic Resistance Transfer and Rapid Plasmid Evolution in a Hospital Setting by Nanopore Sequencing.
- Author
-
Peter S, Bosio M, Gross C, Bezdan D, Gutierrez J, Oberhettinger P, Liese J, Vogel W, Dörfel D, Berger L, Marschal M, Willmann M, Gut I, Gut M, Autenrieth I, and Ossowski S
- Subjects
- Anti-Bacterial Agents pharmacology, Gene Transfer, Horizontal, Genomics, Hospitals, Humans, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa enzymology, Pseudomonas aeruginosa genetics, beta-Lactamases genetics, Drug Resistance, Multiple, Bacterial, Evolution, Molecular, Nanopore Sequencing, Plasmids genetics, Sequence Analysis, DNA methods
- Abstract
Infections with multidrug-resistant bacteria often leave limited or no treatment options. The transfer of antimicrobial resistance genes (ARG) carrying plasmids between bacterial species by horizontal gene transfer represents an important mode of expansion of ARGs. Here, we demonstrate the application of Nanopore sequencing in a hospital setting for monitoring transfer and rapid evolution of antibiotic resistance plasmids within and across multiple species. In 2009, we experienced an outbreak with extensively multidrug-resistant Pseudomonas aeruginosa harboring the carbapenemase-encoding bla
IMP-8 gene. In 2012, the first Citrobacter freundii and Citrobacter cronae strains harboring the same gene were detected. Using Nanopore and Illumina sequencing, we conducted comparative analysis of all blaIMP-8 bacteria isolated in our hospital over a 6-year period ( n = 54). We developed the computational platform plasmIDent for Nanopore-based characterization of clinical isolates and monitoring of ARG transfer, comprising de novo assembly of genomes and plasmids, plasmid circularization, ARG annotation, comparative genome analysis of multiple isolates, and visualization of results. Using plasmIDent , we identified a 40-kb plasmid carrying blaIMP-8 in P. aeruginosa and C. freundii , verifying the plasmid transfer. Within C. freundii , the plasmid underwent further evolution and plasmid fusion, resulting in a 164-kb megaplasmid, which was transferred to C. cronae Multiple rearrangements of the multidrug resistance gene cassette were detected in P. aeruginosa , including deletions and translocations of complete ARGs. In summary, plasmid transfer, plasmid fusion, and rearrangement of the ARG cassette mediated the rapid evolution of opportunistic pathogens in our hospital. We demonstrated the feasibility of near-real-time monitoring of plasmid evolution and ARG transfer in clinical settings, enabling successful countermeasures to contain plasmid-mediated outbreaks. IMPORTANCE Infections with multidrug-resistant bacteria represent a major threat to global health. While the spread of multidrug-resistant bacterial clones is frequently studied in the hospital setting, surveillance of the transfer of mobile genetic elements between different bacterial species was difficult until recent advances in sequencing technologies. Nanopore sequencing technology was applied to track antimicrobial gene transfer in a long-term outbreak of multidrug-resistant Pseudomonas aeruginosa , Citrobacter freundii , and Citrobacter cronae in a German hospital over 6 years. We developed a novel computational pipeline, pathoLogic , which enables de novo assembly of genomes and plasmids, antimicrobial resistance gene annotation and visualization, and comparative analysis. Applying this approach, we detected plasmid transfer between different bacterial species as well as plasmid fusion and frequent rearrangements of the antimicrobial resistance gene cassette. This study demonstrated the feasibility of near-real-time tracking of plasmid-based antimicrobial resistance gene transfer in hospitals, enabling countermeasures to contain plasmid-mediated outbreaks., (Copyright © 2020 Peter et al.)- Published
- 2020
- Full Text
- View/download PDF
140. Description of Citrobacter cronae sp. nov., isolated from human rectal swabs and stool samples.
- Author
-
Oberhettinger P, Schüle L, Marschal M, Bezdan D, Ossowski S, Dörfel D, Vogel W, Rossen JW, Willmann M, and Peter S
- Subjects
- Bacterial Typing Techniques, Base Composition, Citrobacter isolation & purification, DNA, Bacterial genetics, Fatty Acids chemistry, Genes, Bacterial, Germany, Humans, Immunocompromised Host, Multilocus Sequence Typing, Nucleic Acid Hybridization, RNA, Ribosomal, 16S genetics, Sequence Analysis, DNA, Citrobacter classification, Feces microbiology, Phylogeny, Rectum microbiology
- Abstract
Nine independent Gram-negative bacterial strains were isolated from rectal swabs or stool samples of immunocompromised patients from two different wards of a university hospital. All isolates were phylogenetically analysed based on their 16S rRNA gene sequence, housekeeping gene recN , multilocus sequence analysis of concatenated partial fusA , leuS , pyrG and rpoB sequences, and by whole genome sequencing data. The analysed strains of the new species cluster together and form a separate branch with Citrobacter werkmanii NBRC105721
T as the most closely related species. An average nucleotide identity value of 95.9-96% and computation of digital DNA-DNA hybridization values separate the new species from all other type strains of the genus Citrobacter . Biochemical characteristics further delimit the isolates from closely related Citrobacter type strains. As a result of the described data, a new Citrobacter species is introduced, for which the name Citrobacter cronae sp. nov. is proposed. The type strain is Tue2-1T with a G+C DNA content of 52.2 mol%.- Published
- 2020
- Full Text
- View/download PDF
141. Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
- Author
-
Sonnabend MS, Klein K, Beier S, Angelov A, Kluj R, Mayer C, Groß C, Hofmeister K, Beuttner A, Willmann M, Peter S, Oberhettinger P, Schmidt A, Autenrieth IB, Schütz M, and Bohn E
- Subjects
- Bacterial Proteins metabolism, Cefepime pharmacology, Endopeptidases deficiency, Endopeptidases genetics, Gene Deletion, Gene Expression Regulation, Bacterial, Glycosyltransferases deficiency, Glycosyltransferases genetics, Humans, Meropenem pharmacology, Microbial Sensitivity Tests, Mutagenesis, Phosphotransferases (Alcohol Group Acceptor) deficiency, Phosphotransferases (Alcohol Group Acceptor) genetics, Pseudomonas Infections drug therapy, Pseudomonas Infections microbiology, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa enzymology, Pseudomonas aeruginosa isolation & purification, beta-Lactamases genetics, beta-Lactamases metabolism, Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, DNA Transposable Elements, Drug Resistance, Multiple, Bacterial genetics, Pseudomonas aeruginosa genetics, beta-Lactam Resistance genetics
- Abstract
With the aim to identify potential new targets to restore antimicrobial susceptibility of multidrug-resistant (MDR) Pseudomonas aeruginosa isolates, we generated a high-density transposon (Tn) insertion mutant library in an MDR P. aeruginosa bloodstream isolate (isolate ID40). The depletion of Tn insertion mutants upon exposure to cefepime or meropenem was measured in order to determine the common resistome for these clinically important antipseudomonal β-lactam antibiotics. The approach was validated by clean deletions of genes involved in peptidoglycan synthesis/recycling, such as the genes for the lytic transglycosylase MltG, the murein (Mur) endopeptidase MepM1, the MurNAc/GlcNAc kinase AmgK, and the uncharacterized protein YgfB, all of which were identified in our screen as playing a decisive role in survival after treatment with cefepime or meropenem. We found that the antibiotic resistance of P. aeruginosa can be overcome by targeting usually nonessential genes that turn essential in the presence of therapeutic concentrations of antibiotics. For all validated genes, we demonstrated that their deletion leads to the reduction of ampC expression, resulting in a significant decrease in β-lactamase activity, and consequently, these mutants partly or completely lost resistance against cephalosporins, carbapenems, and acylaminopenicillins. In summary, the determined resistome may comprise promising targets for the development of drugs that may be used to restore sensitivity to existing antibiotics, specifically in MDR strains of P. aeruginosa ., (Copyright © 2020 Sonnabend et al.)
- Published
- 2020
- Full Text
- View/download PDF
142. Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.
- Author
-
Gamperl S, Stefanzl G, Peter B, Smiljkovic D, Bauer K, Willmann M, Valent P, and Hadzijusufovic E
- Subjects
- Adenine analogs & derivatives, Agammaglobulinaemia Tyrosine Kinase genetics, Agammaglobulinaemia Tyrosine Kinase metabolism, Animals, Cell Line, Tumor, Cell Survival drug effects, Dogs, Gene Expression Regulation, Neoplastic drug effects, Immunoglobulin E pharmacology, Mastocytoma drug therapy, Piperidines, STAT5 Transcription Factor genetics, STAT5 Transcription Factor metabolism, Cell Proliferation drug effects, Dog Diseases drug therapy, Histamine metabolism, Mastocytoma veterinary, Pyrazoles pharmacology, Pyrimidines pharmacology
- Abstract
The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib is effective in the treatment of human chronic lymphocytic leukaemia and mantle cell lymphoma. Recent data have shown that ibrutinib also blocks IgE-dependent activation and histamine release in human basophils (BAs) and mast cells (MCs). The aim of this study was to investigate whether BTK serves as a novel therapeutic target in canine mast cell tumours (MCTs). We evaluated the effects of ibrutinib on two canine MC lines, C2 and NI-1 and on primary MCs obtained from canine MCTs (n = 3). Using flow cytometry, we found that ibrutinib suppresses phosphorylation of BTK and of downstream STAT5 in both MC lines. In addition, ibrutinib decreased proliferation of neoplastic MCs, with IC
50 values ranging between 0.1 and 1 μM in primary MCT cells and between 1 and 3 μM in C2 and NI-1 cells. In C2 cells, the combination "ibrutinib + midostaurin" produced synergistic growth-inhibitory effects. At higher concentrations, ibrutinib also induced apoptosis in both MC lines. Finally, ibrutinib was found to suppress IgE-dependent histamine release in primary MCT cells, with IC50 values ranging from 0.05 to 0.1 μM in NI-1 cells, and from 0.05 to 1 μM in primary MCT cells. In summary, ibrutinib exerts anti-proliferative effects in canine neoplastic MCs and counteracts IgE-dependent histamine release in these cells. Based on our data, ibrutinib may be considered as a novel therapeutic agent for the treatment of canine MCT. The value of BTK inhibition in canine MCT patients remains to be elucidated in clinical trials., (© 2019 The Authors. Veterinary and Comparative Oncology published by John Wiley & Sons Ltd.)- Published
- 2019
- Full Text
- View/download PDF
143. In Vivo Characterization of Tick-Borne Encephalitis Virus in Bank Voles ( Myodes glareolus ).
- Author
-
Michelitsch A, Tews BA, Klaus C, Bestehorn-Willmann M, Dobler G, Beer M, and Wernike K
- Subjects
- Animals, Antibodies, Viral immunology, Cell Line, Cells, Cultured, Disease Reservoirs virology, Encephalitis Viruses, Tick-Borne isolation & purification, Humans, Immunoassay, RNA, Viral, Reverse Transcriptase Polymerase Chain Reaction, Rodent Diseases diagnosis, Symptom Assessment, Arvicolinae virology, Encephalitis Viruses, Tick-Borne physiology, Encephalitis, Tick-Borne veterinary, Rodent Diseases virology
- Abstract
Tick-borne encephalitis is the most important tick-transmitted zoonotic virus infection in Eurasia, causing severe neurological symptoms in humans. The causative agent, the tick-borne encephalitis virus (TBEV), circulates between ticks and a variety of mammalian hosts. To study the interaction between TBEV and one of its suspected reservoir hosts, bank voles of the Western evolutionary lineage were inoculated subcutaneously with either one of eight TBEV strains or the related attenuated Langat virus, and were euthanized after 28 days. In addition, a subset of four strains was characterized in bank voles of the Carpathian linage. Six bank voles were inoculated per strain, and were housed together in groups of three with one uninfected in-contact animal each. Generally, most bank voles did not show any clinical signs over the course of infection. However, one infected bank vole died and three had to be euthanized prematurely, all of which had been inoculated with the identical TBEV strain (Battaune 17-H9, isolated in 2017 in Germany from a bank vole). All inoculated animals seroconverted, while none of the in-contact animals did. Viral RNA was detected via real-time RT-PCR in the whole blood samples of 31 out of 74 inoculated and surviving bank voles. The corresponding serum sample remained PCR-negative in nearly all cases (29/31). In addition, brain and/or spine samples tested positive in 11 cases, mostly correlating with a positive whole blood sample. Our findings suggest a good adaption of TBEV to bank voles, combining in most cases a low virulence phenotype with detectable virus replication and hinting at a reservoir host function of bank voles for TBEV., Competing Interests: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
- Published
- 2019
- Full Text
- View/download PDF
144. Identification of a leukemia-initiating stem cell in human mast cell leukemia.
- Author
-
Eisenwort G, Sadovnik I, Schwaab J, Jawhar M, Keller A, Stefanzl G, Berger D, Blatt K, Hoermann G, Bilban M, Willmann M, Winding C, Sperr WR, Arock M, Rülicke T, Reiter A, and Valent P
- Subjects
- ADP-ribosyl Cyclase 1 metabolism, Adult, Aged, Aged, 80 and over, Animals, Antigens, CD34 metabolism, Cell Transformation, Neoplastic, Dipeptidyl Peptidase 4 metabolism, Female, Gene Expression Regulation, Leukemic, Humans, Immunophenotyping, Interleukin-2 Receptor alpha Subunit metabolism, Leukemia, Myeloid, Acute pathology, Male, Mice, Mice, Inbred NOD, Mice, SCID, Middle Aged, Neoplastic Stem Cells classification, Sialic Acid Binding Ig-like Lectin 3 metabolism, Transplantation, Heterologous, Leukemia pathology, Leukemia, Mast-Cell pathology, Neoplastic Stem Cells cytology
- Abstract
Mast cell leukemia (MCL) is a highly fatal malignancy characterized by devastating expansion of immature mast cells in various organs. Although considered a stem cell disease, little is known about MCL-propagating neoplastic stem cells. We here describe that leukemic stem cells (LSCs) in MCL reside within a CD34
+ /CD38- fraction of the clone. Whereas highly purified CD34+ /CD38─ cells engrafted NSGhSCF mice with fully manifesting MCL, no MCL was produced by CD34+ /CD38+ progenitors or the bulk of KIT+ /CD34- mast cells. CD34+ /CD38- MCL cells invariably expressed CD13 and CD133, and often also IL-1RAP, but did not express CD25, CD26 or CLL-1. CD34+ /CD38- MCL cells also displayed several surface targets, including CD33, which was homogenously expressed on MCL LSCs in all cases, and the D816V mutant form of KIT. Although CD34+ /CD38- cells were resistant against single drugs, exposure to combinations of CD33-targeting and KIT-targeting drugs resulted in LSC-depletion and markedly reduced engraftment in NSGhSCF mice. Together, MCL LSCs are CD34+ /CD38- cells that express distinct profiles of markers and target antigens. Characterization of MCL LSCs should facilitate their purification and should support the development of LSC-eradicating curative treatment approaches in this fatal type of leukemia.- Published
- 2019
- Full Text
- View/download PDF
145. Pathogenicity of Clinical OXA-48 Isolates and Impact of the OXA-48 IncL Plasmid on Virulence and Bacterial Fitness.
- Author
-
Hamprecht A, Sommer J, Willmann M, Brender C, Stelzer Y, Krause FF, Tsvetkov T, Wild F, Riedel-Christ S, Kutschenreuter J, Imirzalioglu C, Gonzaga A, Nübel U, and Göttig S
- Abstract
OXA-48 is the most common carbapenemase in Enterobacterales in Germany and one of the most frequent carbapenemases worldwide. Several reports have associated bla
OXA - 48 with a virulent host phenotype. To challenge this hypothesis, 35 OXA-48-producing clinical isolates of Escherichia coli ( n = 15) and Klebsiella pneumoniae ( n = 20) were studied in vitro , in vivo employing the Galleria mellonella infection model and by whole-genome sequencing. Clinical isolates belonged to 7 different sequence types (STs) in E. coli and 12 different STs in K. pneumoniae . In 26/35 isolates blaOXA- 48 was located on a 63 kb IncL plasmid. Horizontal gene transfer (HGT) to E. coli J53 was high in isolates with the 63 kb IncL plasmid (transconjugation frequency: ∼103 /donor) but low in isolates with non-IncL plasmids (<10-6 /donor). Several clinical isolates were both highly cytotoxic against human cells and virulent in vivo . However, 63 kb IncL transconjugants generated from these highly virulent isolates were not more cytotoxic or virulent when compared to the recipient strain. Additionally, no genes associated with virulence were detected by in silico analysis of OXA-48 plasmids. The 63 kb plasmid was highly stable and did not impair growth or fitness in E. coli J53. In conclusion, OXA-48 clinical isolates in Germany are diverse but typically harbor the same 63 kb IncL plasmid which has been reported worldwide. We demonstrate that this 63 kb IncL plasmid has a low fitness burden, high plasmid stability and can be transferred by highly efficient HGT which is likely the cause of the rapid dissemination of OXA-48 rather than the expansion of a single clone or gain of virulence., (Copyright © 2019 Hamprecht, Sommer, Willmann, Brender, Stelzer, Krause, Tsvetkov, Wild, Riedel-Christ, Kutschenreuter, Imirzalioglu, Gonzaga, Nübel and Göttig.)- Published
- 2019
- Full Text
- View/download PDF
146. Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study.
- Author
-
Willmann M, Vehreschild MJGT, Biehl LM, Vogel W, Dörfel D, Hamprecht A, Seifert H, Autenrieth IB, and Peter S
- Subjects
- Anti-Bacterial Agents therapeutic use, Ciprofloxacin therapeutic use, Cohort Studies, Genes, Bacterial drug effects, Germany, Humans, Longitudinal Studies, Metagenomics methods, Trimethoprim, Sulfamethoxazole Drug Combination therapeutic use, Anti-Bacterial Agents adverse effects, Ciprofloxacin adverse effects, Drug Resistance, Microbial drug effects, Drug Resistance, Microbial genetics, Gastrointestinal Microbiome drug effects, Plasmids drug effects, Trimethoprim, Sulfamethoxazole Drug Combination adverse effects
- Abstract
Background: The selection pressure exercised by antibiotic drugs is an important consideration for the wise stewardship of antimicrobial treatment programs. Treatment decisions are currently based on crude assumptions, and there is an urgent need to develop a more quantitative knowledge base that can enable predictions of the impact of individual antibiotics on the human gut microbiome and resistome., Results: Using shotgun metagenomics, we quantified changes in the gut microbiome in two cohorts of hematological patients receiving prophylactic antibiotics; one cohort was treated with ciprofloxacin in a hospital in Tübingen and the other with cotrimoxazole in a hospital in Cologne. Analyzing this rich longitudinal dataset, we found that gut microbiome diversity was reduced in both treatment cohorts to a similar extent, while effects on the gut resistome differed. We observed a sharp increase in the relative abundance of sulfonamide antibiotic resistance genes (ARGs) by 148.1% per cumulative defined daily dose of cotrimoxazole in the Cologne cohort, but not in the Tübingen cohort treated with ciprofloxacin. Through multivariate modeling, we found that factors such as individual baseline microbiome, resistome, and plasmid diversity; liver/kidney function; and concurrent medication, especially virostatic agents, influence resistome alterations. Strikingly, we observed different effects on the plasmidome in the two treatment groups. There was a substantial increase in the abundance of ARG-carrying plasmids in the cohort treated with cotrimoxazole, but not in the cohort treated with ciprofloxacin, indicating that cotrimoxazole might contribute more efficiently to the spread of resistance., Conclusions: Our study represents a step forward in developing the capability to predict the effect of individual antimicrobials on the human microbiome and resistome. Our results indicate that to achieve this, integration of the individual baseline microbiome, resistome, and mobilome status as well as additional individual patient factors will be required. Such personalized predictions may in the future increase patient safety and reduce the spread of resistance., Trial Registration: ClinicalTrials.gov, NCT02058888 . Registered February 10 2014.
- Published
- 2019
- Full Text
- View/download PDF
147. Oxidative stress drives the selection of quorum sensing mutants in the Staphylococcus aureus population.
- Author
-
George SE, Hrubesch J, Breuing I, Vetter N, Korn N, Hennemann K, Bleul L, Willmann M, Ebner P, Götz F, and Wolz C
- Subjects
- Bacterial Proteins genetics, Bacterial Toxins pharmacology, Evolution, Molecular, Gene Expression Regulation, Bacterial, Staphylococcal Infections genetics, Staphylococcal Infections metabolism, Staphylococcus aureus drug effects, Staphylococcus aureus pathogenicity, Trans-Activators genetics, Virulence, Bacterial Proteins metabolism, Mutation, Oxidative Stress, Quorum Sensing, Staphylococcal Infections microbiology, Staphylococcus aureus genetics, Trans-Activators metabolism
- Abstract
Quorum sensing (QS) is the central mechanism by which social interactions within the bacterial community control bacterial behavior. QS-negative cells benefit by exploiting public goods produced by the QS-proficient population. Mechanisms to keep the balance between producers and nonproducers within the population are expected but have not been elucidated for peptide-based QS systems in gram-positive pathogens. The Agr system of Staphylococcus aureus comprises the secretion and sensing of an autoinducing peptide to activate its own expression via the response regulator AgrA as well as the expression of a regulatory RNAIII and psm α /psm ß coding for phenol-soluble modulins (PSMs). Agr mutants can be monitored on blood agar due to their nonhemolytic phenotype. In vitro evolution and competition experiments show that they readily accumulate in a process that is accelerated by ciprofloxacin, while the wild type (WT) is retained in the population at low numbers. However, agr mutants possess a fitness advantage only under aerobic conditions. Under hypoxia, Agr activity is increased but without the expected fitness cost. The Agr-imposed oxygen-dependent fitness cost is not due to a metabolic burden but due to the reactive oxygen species (ROS)-inducing capacity of the PSMs and RNAIII-regulated factors. Thus, selection of mutants is dictated by the QS system itself. Under aerobic conditions, emergence of agr -negative mutants may provide the population with a fitness advantage while hypoxia favors QS maintenance and even affords increased toxin production. The oxygen-driven tuning of the Agr system might be of importance to provide the pathogen with capabilities crucial for disease progression., Competing Interests: The authors declare no conflict of interest.
- Published
- 2019
- Full Text
- View/download PDF
148. Molecular Evolution of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa Strains From Patients and Hospital Environment in a Prolonged Outbreak.
- Author
-
Buhl M, Kästle C, Geyer A, Autenrieth IB, Peter S, and Willmann M
- Abstract
In this study, we aimed to elucidate a prolonged outbreak of extensively drug-resistant (XDR) Pseudomonas aeruginosa , at two adjacent hospitals over a time course of 4 years. Since all strains exhibited a similar antibiotic susceptibility pattern and carried the carbapenemase gene bla
VIM , a monoclonal outbreak was assumed. To shed light on the intra-hospital evolution of these strains over time, whole genome sequence (WGS) analysis of 100 clinical and environmental outbreak strains was employed. Phylogenetic analysis of the core genome revealed the outbreak to be polyclonal, rather than monoclonal as initially suggested. The vast majority of strains fell into one of two major clusters, composed of 27 and 59 strains, and their accessory genome each revealed over 400 and 600 accessory genes, respectively, thus indicating an unexpectedly high structural diversity among phylogenetically clustered strains. Further analyses focused on the cluster with 59 strains, representing the hospital from which both clinical and environmental strains were available. Our investigation clearly shows both accumulation and loss of genes occur very frequently over time, as reflected by analysis of protein enrichment as well as functional enrichment. In addition, we investigated adaptation through single nucleotide polymorphisms (SNPs). Among the genes affected by SNPs, there are a multidrug efflux pump ( mexZ ) and a mercury detoxification operon ( merR ) with deleterious mutations, potentially leading to loss of repression with resistance against antibiotics and disinfectants. Our results not only confirm WGS to be a powerful tool for epidemiologic analyses, but also provide insights into molecular evolution during an XDR P. aeruginosa hospital outbreak. Genome mutation unveiled a striking genetic plasticity on an unexpectedly high level, mostly driven by horizontal gene transfer. Our study adds valuable information to the molecular understanding of "real-world" Intra-hospital P. aeruginosa evolution and is a step forward toward more personalized medicine in infection control.- Published
- 2019
- Full Text
- View/download PDF
149. Expansion of Vancomycin-Resistant Enterococcus faecium in an Academic Tertiary Hospital in Southwest Germany: a Large-Scale Whole-Genome-Based Outbreak Investigation.
- Author
-
Liese J, Schüle L, Oberhettinger P, Tschörner L, Nguyen T, Dörfel D, Vogel W, Marschal M, Autenrieth I, Willmann M, and Peter S
- Subjects
- Enterococcus faecium drug effects, Enterococcus faecium genetics, Genome, Bacterial genetics, Germany, Humans, Microbial Sensitivity Tests, Multilocus Sequence Typing, Vancomycin-Resistant Enterococci drug effects, Vancomycin-Resistant Enterococci genetics, Anti-Bacterial Agents pharmacology, Vancomycin pharmacology
- Abstract
Vancomycin-resistant Enterococcus faecium (VREfm) is a frequent cause of nosocomial outbreaks. In the second half of 2015, a sharp increase in the incidence of VREfm was observed at our university medical center. Next-generation sequencing (NGS) was used to analyze the first isolates of VREfm recovered from patients between 2010 and 2016 ( n = 773) in order to decipher epidemiological change, outbreak dynamics, and possible transmission routes. VREfm isolates were analyzed using whole-genome sequencing followed by sequence type extraction and phylogenetic analysis. We examined epidemiological data, room occupancy data, and patient transferals and calculated an intensity score for patient-to-patient contact. Phylogenetic analysis revealed the presence of 38 NGS clusters and 110 single clones. The increase of VREfm was caused mainly by the expansion of two newly introduced NGS clusters, comprising VanB-type strains determined by multilocus sequence typing (MLST) as sequence type 80 (ST80) and ST117. By combining phylogenetic information with epidemiological data, intrahospital transmission could be demonstrated, however to a lesser extent than initially expected based solely on epidemiological data. The outbreak clones were continuously imported from other hospitals, suggesting a change in the epidemiological situation at a regional scale. By tracking intrahospital patient transferals, two major axes could be identified that contributed to the spread of VREfm within the hospital. NGS-based outbreak analysis revealed a dramatic change in the local and regional epidemiology of VREfm, emphasizing the role of health care networks in the spread of VREfm., (Copyright © 2019 American Society for Microbiology.)
- Published
- 2019
- Full Text
- View/download PDF
150. Transparent high-pressure nozzles for visualization of nozzle internal and external flow phenomena.
- Author
-
Kirsch V, Hermans M, Schönberger J, Ruoff I, Willmann M, Reisgen U, Kneer R, and Reddemann MA
- Abstract
A new design for transparent high-pressure nozzles is presented in this work. This new design enables using the innovative Selective Laser Etching (SLE) method to manufacture transparent nozzles with outstanding accuracy. Therefore, not only the simultaneous visualization of the flow mechanics inside and outside the nozzle is enabled, but the manufacturing method applied also allows for the realization of individual nozzle geometries. Thus, nozzle internal flow phenomena (e.g., cavitation, swirl, and air inlet) and their influence on primary breakup can be analyzed with realistic nozzle geometries, e.g., for automotive applications. In addition, targeted three dimensional nozzle geometric parameters can be designed and manufactured in order to get specific tailor-made spray characteristics (e.g., droplet size distribution, spray angle, and penetration length). The basis for the transparent nozzle design is a two-parted nozzle, consisting of a re-machined original serial nozzle body and a transparent nozzle tip. The innovative SLE is used to produce the geometry of the transparent nozzle tip in fused silica, and laser polishing is utilized to achieve a maximum optical quality of nozzle surfaces for visualization. Bonding of both nozzle parts is achieved by a specially designed adhesive method. For a first feasibility study, a transparent nozzle with a simplified nozzle geometry is manufactured and used for a first study. In this study, simultaneous investigation of nozzle internal flow phenomena and their impact on spray breakup are visualized. First microscopic images of the nozzle internal flow show the formation of cavitation, its effect on nozzle internal temperature (apparent by differences in the fluid refractive index), and also the corresponding impact on spray breakup during injection. The penetration of ambient gas into the nozzle is verified at the end of injection as well as the influence of this air on the spray formation during the start of injection.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.